Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | SC262 |
Trade Name | |
Synonyms | SC-262|SC 262 |
Drug Descriptions |
Limited information is currently available on SC262, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD22 (May 2024). |
DrugClasses | CD22 Immune Cell Therapy 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SC262 | SC262 | 0 | 1 |